603579 荣泰健康
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入1,148,151-1.39%1,596,8681,855,0292,004,8212,612,570
减:营业总成本1,091,0816.16%1,435,0261,641,6151,828,5832,402,410
    其中:营业成本779,656-1.23%1,090,9771,288,3641,473,0691,911,466
               财务费用17,009-297.56%(15,920)(14,889)(21,450)36,446
               资产减值损失(2,027)6.13%(5,047)(6,615)(3,285)(1,192)
公允价值变动收益3,693-501.11%(6,142)(16,219)10,4104,694
投资收益44,992145.26%38,84029,26419,57194,802
    其中:对联营企业和合营企业的投资收益14,06130.12%12,9531,5352133,366
营业利润128,936-18.31%210,400235,955186,537265,225
利润总额130,092-17.45%209,994230,192179,373260,964
减:所得税费用19,22429.96%18,18626,86014,65332,931
净利润110,868-22.36%191,808203,332164,720228,034
减:非控股权益47-83.29%(138)625492(8,302)
股东净利润110,822-22.24%191,946202,707164,228236,336

市场价值指针
每股收益 (元) *0.630-23.17%1.1101.1701.2301.750
每股派息 (元) *----0.6501.0000.5000.700
每股净资产 (元) *13.51327.65%11.11313.85913.02612.382
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容